CY1115295T1 - Συνθεση για την θεραπεια παθολογιας συνδεομενης με msrv/herv-w - Google Patents

Συνθεση για την θεραπεια παθολογιας συνδεομενης με msrv/herv-w

Info

Publication number
CY1115295T1
CY1115295T1 CY20141100404T CY141100404T CY1115295T1 CY 1115295 T1 CY1115295 T1 CY 1115295T1 CY 20141100404 T CY20141100404 T CY 20141100404T CY 141100404 T CY141100404 T CY 141100404T CY 1115295 T1 CY1115295 T1 CY 1115295T1
Authority
CY
Cyprus
Prior art keywords
herv
msrv
synthesis
soluble
pathology consultation
Prior art date
Application number
CY20141100404T
Other languages
English (en)
Inventor
Patrice Marche
Alexandre Rolland
Evelyne Jouvin-Marche
Hervé Perron
Original Assignee
bioMérieux
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by bioMérieux filed Critical bioMérieux
Publication of CY1115295T1 publication Critical patent/CY1115295T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1036—Retroviridae, e.g. leukemia viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Neurosurgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Psychiatry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Σύνθεση που περιλαμβάνει τουλάχιστον ένα αντίσωμα επιλεγμένο από την ομάδα (i) των αντισωμάτων αντι-Env-SU MSRV/HERV-W ή από την ομάδα (ii) των αντισωμάτων αντι-TLR4 ικανών να συνδέονται ειδικά στο διαλυτό κλάσμα της πρωτεΐνης Env του MSRV/HERV-W ή στον υποδοχέα TLR4 του διαλυτού κλάσματος της πρωτεΐνης Env του MSRV/HERV-W, και ένα φαρμακευτικά αποδεκτό όχημα.
CY20141100404T 2004-01-23 2014-06-06 Συνθεση για την θεραπεια παθολογιας συνδεομενης με msrv/herv-w CY1115295T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0400675A FR2865403B1 (fr) 2004-01-23 2004-01-23 Composition pour le traitement d'une pathologie associee a la msrv/herv-w
EP05717480.7A EP1709082B1 (fr) 2004-01-23 2005-01-24 Composition pour le traitement d' une pathologie associee a la msrv/herv-w

Publications (1)

Publication Number Publication Date
CY1115295T1 true CY1115295T1 (el) 2017-01-04

Family

ID=34717397

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20141100404T CY1115295T1 (el) 2004-01-23 2014-06-06 Συνθεση για την θεραπεια παθολογιας συνδεομενης με msrv/herv-w

Country Status (17)

Country Link
US (1) US7666420B2 (el)
EP (3) EP3133087A1 (el)
JP (1) JP4991314B2 (el)
KR (1) KR20070001149A (el)
CN (1) CN1926153B (el)
AU (1) AU2005214107A1 (el)
BR (1) BRPI0507019A (el)
CA (1) CA2554263C (el)
CY (1) CY1115295T1 (el)
DK (1) DK1709082T3 (el)
ES (1) ES2466790T3 (el)
FR (1) FR2865403B1 (el)
IL (1) IL176829A0 (el)
PL (1) PL1709082T3 (el)
PT (1) PT1709082E (el)
SI (1) SI1709082T1 (el)
WO (1) WO2005080437A1 (el)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2897062B1 (fr) 2006-02-09 2011-11-04 Biomerieux Sa Domaine peptidique necessaire a l'interaction entre l'enveloppe d'un virus appartenant au groupe d'interference de herv-w et un recepteur asct
FR2912314B1 (fr) * 2007-02-09 2012-08-03 Geneuro Sa Composition pharmaceutique comprenant des anticorps diriges contre l'enveloppe de herv-w.
PT2315777T (pt) * 2008-07-08 2017-07-25 Geneuro Sa Uso terapêutico de ligandos específicos nas doenças associadas a msrv
WO2012118974A2 (en) * 2011-03-01 2012-09-07 University Of Medicine And Dentistry Of New Jersey Detection of human endogenous retrovirus expression in cancer and normal cells
US10370417B2 (en) 2011-03-01 2019-08-06 Rutgers, The State University Of New Jersey Methods for the diagnosis of cancer through detection of human endogenous retrovirus WL (HERV-WL) envelope expression
UA119032C2 (uk) * 2012-10-02 2019-04-25 Женеро Са Фармацевтична композиція для лікування блокади ремієлінізації при захворюваннях, які пов'язані з експресією білка оболонки herv-w
CN103319600B (zh) * 2013-06-19 2014-12-17 南京军区军事医学研究所 一种人源抗TLR4抗体Fab及其制备方法与应用
EP2949342A1 (en) * 2014-05-28 2015-12-02 Geneuro SA Antiretroviral drug targeting human endogenous retrovirus
WO2017059122A1 (en) 2015-09-29 2017-04-06 The United States Of America, As Represented By The Secretary, Department Of Health And Human Methods of treating and preventing amyotrophic lateral sclerosis
EP3351265A1 (en) * 2017-01-20 2018-07-25 Geneuro SA Anti-herv-k envelope antibody and uses thereof
EP3916015A1 (en) * 2020-05-28 2021-12-01 Geneuro SA Anti-herv-w envelope protein antibody for use in the treatment of psychotic diseases

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69533863T2 (de) * 1994-02-04 2006-02-16 Bio Merieux MSRV1 Virus der mit Multipler Sklerose verbunden ist, seine nukleären Bestandteile und Verwendungen
FR2780069B1 (fr) * 1998-06-23 2002-06-28 Inst Nat Sante Rech Med Famille de sequences nucleiques et de sequences proteiques deduites presentant des motifs retroviraux endogenes humains et leurs applications
FR2797889A1 (fr) * 1999-09-01 2001-03-02 Bio Merieux Procede de detection de l'expression d'une proteine d'enveloppe d'un retrovirus endogene humain et utilisations d'un gene codant pour cette proteine
EP1224291A1 (en) * 1999-10-28 2002-07-24 Universite De Geneve Multiple sclerosis-related superantigen
US20030077279A1 (en) * 2001-10-24 2003-04-24 Cedars-Sinai Medical Center Methods for treating vascular disease by inhibiting toll-like receptor-4
JP2004016021A (ja) * 2002-06-12 2004-01-22 Japan Science & Technology Corp 抗体および阻害剤並びにそれを用いた形質転換方法および形質転換キット

Also Published As

Publication number Publication date
CA2554263A1 (fr) 2005-09-01
WO2005080437A1 (fr) 2005-09-01
US20080038279A1 (en) 2008-02-14
CN1926153A (zh) 2007-03-07
FR2865403B1 (fr) 2009-06-12
JP2008505847A (ja) 2008-02-28
AU2005214107A1 (en) 2005-09-01
KR20070001149A (ko) 2007-01-03
EP1709082B1 (fr) 2014-03-12
ES2466790T3 (es) 2014-06-11
EP1709082A1 (fr) 2006-10-11
EP2365002A2 (fr) 2011-09-14
US7666420B2 (en) 2010-02-23
CN1926153B (zh) 2011-05-04
CA2554263C (fr) 2014-08-05
JP4991314B2 (ja) 2012-08-01
PL1709082T3 (pl) 2015-02-27
BRPI0507019A (pt) 2007-06-05
PT1709082E (pt) 2014-06-25
DK1709082T3 (da) 2014-06-16
EP3133087A1 (fr) 2017-02-22
SI1709082T1 (sl) 2014-07-31
IL176829A0 (en) 2006-10-31
EP2365002A3 (fr) 2012-05-02
FR2865403A1 (fr) 2005-07-29

Similar Documents

Publication Publication Date Title
CY1115295T1 (el) Συνθεση για την θεραπεια παθολογιας συνδεομενης με msrv/herv-w
CY1121536T1 (el) Ανθρωπινα αντισωματα εναντι-αλφα-συνουκλεϊνης
CY1124802T1 (el) Δεσμευτικοι παραγοντες σκληροστινης
CY1120951T1 (el) Ανθρωπινα αντισωματα enanti-tau
CY1114658T1 (el) Πρωτεϊνες δεσμευσης αντιγονου του αυξητικου παραγοντα τυπου επιδερμικου αυξητικου παραγοντα προσδεσης στην ηπαρινη
CY1118713T1 (el) Βιολογικα προϊοντα
EP2360169A3 (en) PSMA antibodies
ES2572231T3 (es) Anticuerpos monoclonales anti-IL-21 humana
NZ594466A (en) Human monoclonal antibodies to protein tyrosine kinase 7 (PTK7) and methods for using anti-PTK7 antibodies
CO5160384A1 (es) Anticuerpo humanizado especifico para 4-1bb humano y composicion farmaceutica que comprende el mismo
GEP20094829B (en) Fully human antibodies against human 4-1bb (cd137)
WO2005103081A3 (en) Human monoclonal antibodies against cd20
CY1111518T1 (el) Tgf βητα 1 ειδικα αντισωματα
CO6231038A2 (es) Proteinas de union, incluyendo anticuerpos derivados de anticuerpo y fragmentos de anticuerpo que se unen especificamente a cd154 y sus usos
CY1110689T1 (el) Συνθεσεις οι οποιες περιλαμβανουν πολυπεπτιδια
NO20063569L (no) M-CSF-spesifikt monoklonalt antistoff og anvendelse derav
CL2012003245A1 (es) Proteína de unión a antígeno aislada que se une a linfopoyetina estromal tímica (tslp); composición que comprende una proteína de unión a antígeno que une tslp correspondiente a un anticuerpo humano anti-tslp.
AR059809A1 (es) Anticuerpos anti-5t4 y sus usos
BR112012006492A2 (pt) proteína de fusão de anticorpo multivalente, e, ligação de albumina
WO2003100033A3 (en) ANTI-αvβ6 ANTIBODIES
WO2008031577A8 (en) Human anti-folate receptor alpha antibodies and antibody fragments for the radioimmunotherapy of ovarian carcinoma
ATE391174T1 (de) Modifizierter tpo-agonisten antikörper
CY1108545T1 (el) Πρωτεϊνες υπομοναδας υποδοχεα κυτοκινης θηλαστικου, σχετικα αντιδραστηρια και μεθοδοι
CL2008001258A1 (es) Kit de vacuna que comprende al menos nueve conjugados de sacaridos de antgenos hb o hib, donde al menos 2-7 son con la proteina transportadora crm, siendo dicho kit adecuado para usar en su calendario de inmunizacion primaria; vacuna combinada adecuada para la inmunizacion primaria.
IL148113A0 (en) Ovarian cancer cell and myeloma cell surface glycoproteins, antibodies thereto, and uses thereof